Skip to content
Directory

Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Directory explains “what it is.”Guides explain how owners can discuss, use, monitor, or prepare for a treatment option with veterinary guidance.
Filtered (6)
Filtered (6)
Filter

Filter

6 directory found

Type
See more See less
Species
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
Product Family
See more See less
Regulatory Status
See more See less
Region / Availability
See more See less
Search
Apply(6) Reset
Show (6)
Cancel
Apply(6) Reset
6 entriesShowing 1–6
Veterinary team coordinating a medication schedule for a dogNamed profile Piroxicam in Veterinary Oncology: NSAID Evidence and Interaction SafetyRepresentative category illustration – no product packaging is shown.
NSAID / Anti-inflammatory · Prescription Drug · Nonsteroidal anti-inflammatory drugs · Dogs · During Chemotherapy · Long-term Management · Palliative / Comfort Care

Piroxicam in Veterinary Oncology: NSAID Evidence and Interaction Safety

piroxicam is covered as nonsteroidal anti-inflammatory drug used extra-label in selected veterinary oncology contexts, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian demonstrating safe handling of an unbranded oral oncology medicine with a dog caregiverNamed profile Temozolomide in Veterinary Oncology: Oral Alkylator and Evidence BoundaryRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Triazene antineoplastic agents · Dogs & Cats · During Chemotherapy · New Diagnosis

Temozolomide in Veterinary Oncology: Oral Alkylator and Evidence Boundary

temozolomide is covered as triazene antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian demonstrating safe handling of an unbranded oral oncology medicine with a dog caregiverNamed profile Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Ribonucleotide-reductase inhibitors · Dogs & Cats · During Chemotherapy · New Diagnosis

Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease Profile

hydroxyurea is covered as ribonucleotide-reductase inhibitors; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian demonstrating safe handling of an unbranded oral oncology medicine with a dog caregiverNamed profile Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Methylhydrazine antineoplastic agents · Dogs & Cats · During Chemotherapy · New Diagnosis

Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety Profile

procarbazine is covered as methylhydrazine antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Calm dog receiving a monitored intravenous treatment in a veterinary clinicNamed profile Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Taxane antineoplastic agents · Dogs · During Chemotherapy · New Diagnosis

Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History Profile

paclitaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Calm dog receiving a monitored intravenous treatment in a veterinary clinicNamed profile Docetaxel in Veterinary Oncology: Limited-Evidence Taxane ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Taxane antineoplastic agents · Dogs · During Chemotherapy · New Diagnosis

Docetaxel in Veterinary Oncology: Limited-Evidence Taxane Profile

docetaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more